Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL0500399	米格列奈钙	Mitiglinide calcium	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2005-03-26	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2006-06-28	view
CXHL0500400	米格列奈钙片	Mitiglinide calcium	Tablet	Chemical Drugs(3.1)	New Drug Application	2005-03-26	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2006-06-28	view
CXL01390	沙利度胺	thalidomide	Active ingredient	Chemical Drugs(2)	New Drug Application	2001-05-25	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2003-09-27	view
CXL01391	沙利度胺片	thalidomide	Tablet	Chemical Drugs(2)	New Drug Application	2001-05-25	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2003-09-27	view
X0306169	草酸依地普仑	escitalopram oxalate	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2004-08-12	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2004-11-22	view
X0306170	草酸依地普仑片	escitalopram oxalate	Tablet	Chemical Drugs(3.1)	New Drug Application	2004-08-12	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2004-11-22	view
X0404823	盐酸美金刚	memantine hydrochloride	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2004-08-26	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2005-03-24	view
X0404824	盐酸美金刚片	memantine hydrochloride	Tablet	Chemical Drugs(3.1)	New Drug Application	2004-08-26	北京赛德维康医药研究院	Beijing Saide Weikang Medicine Institute	Certificate Issued	2005-03-24	view